Education
About Us
Working with TipRanks
Follow Us
Jason Tardio Insider Profile
4 Followers
Jason Tardio, COO at Ovid Therapeutics, holds 12.51K shares in Immunic (Ticker: IMUX), holds 28.13K shares in Ovid Therapeutics (Ticker: OVID). Most recently, Jason Tardio Bought ― shares of Immunic on Jun 09, 2025 for an estimated value of 9.88K.
Jason Tardio has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Jason Tardio
Jason Tardio's Trading History
Ovid Therapeutics
Feb 26, 2024
COO
Uninformative Buy
―
$14.37K
Immunic
Jun 09, 2025
President & COO
Informative Buy
9.88K
$11.29K
List of latest transactions for each holding click on a transaction to see Jason Tardio's performance on stock
You May Also Like
Jason Tardio insider profile FAQ
What is the percentage of profitable transactions made by Jason Tardio?
The percentage of profitable transactions made by Jason Tardio is ―.
What is the average return per transaction made by Jason Tardio?
The average return per transaction made by Jason Tardio is ―.
What stocks does Jason Tardio hold?
Jason Tardio holds: OVID, IMUX stocks.
What was Jason Tardio’s latest transaction?
Jason Tardio latest transaction was an Informative Buy of $9.88K.
What was Jason Tardio's most profitable transaction?
Jason Tardio’s most profitable transaction was an Informative Buy of IMUX stock on June 9, 2025. The return on the trade was 7.30%.
What is Jason Tardio's role in Ovid Therapeutics?
Jason Tardio's role in Ovid Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.